Market Access Capital discipline in biotech: Building enduring companies w... Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.
R&D Closed & Collaborative H2 2025: Mergers, acquisitions, partn... The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.
Market Access Women's health: Predictions for 2026 A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.
Market Access VuuAI and Amiculum partner to transform content engagement i... Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
Digital Sponsored Reimagining digital health partnerships: A practical guide f... With billions invested and digital health initiatives on the rise, why do so few pharma-tech partnerships achieve lasting success?
R&D How pharma companies can build mutually beneficial relations... Seemingly every week, headlines declare new partnerships inked between global pharma giants and previously unknown start-ups.
News Roche develops Bundibugyo Ebola test in six days A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.